ANTITUMOR-ACTIVITY OF THE PROGESTERONE ANTAGONISTS ZK-98.299 AND RU-38.486 IN THE HORMONE-DEPENDENT MXT MAMMARY-TUMOR MODEL OF THE MOUSE AND THE DMBA-INDUCED AND THE MNU-INDUCED MAMMARY-TUMOR MODELS OF THE RAT

被引：65

作者：

SCHNEIDER, MR

MICHNA, H

NISHINO, Y

ELETREBY, MF

机构：

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1989年 / 25卷 / 04期

关键词：

D O I：

10.1016/0277-5379(89)90206-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：691 / &

相关论文

共 24 条

[1] BAKKER GH, 1987, HORMONAL MANIPULATIO, P39
[2] BARDON S, 1987, CANCER RES, V47, P1441
[3] BOGDEN AE, 1978, BREAST CANCER ADV RE, V2, P283
[4] MORPHOLOGY OF MXT MOUSE MAMMARY-TUMORS - CORRELATION WITH GROWTH-CHARACTERISTICS AND HORMONE SENSITIVITY
DANGUY, A
KISS, R
LECLERCQ, G
HEUSON, JC
PASTEELS, JL
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (01): : 69 - 75
[5] STUDIES ON THE MECHANISMS OF ACTION OF PROGESTERONE ANTAGONISTS
ELGER, W
BEIER, S
CHWALISZ, K
FAHNRICH, M
HASAN, SH
HENDERSON, D
NEEF, G
ROHDE, R
[J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1986, 25 (5B) : 835 - 845
[6] DIFFERENCE BETWEEN R5020 AND THE ANTIPROGESTIN RU486 IN ANTIPROLIFERATIVE EFFECTS ON HUMAN-BREAST CANCER-CELLS
GILL, PG
VIGNON, F
BARDON, S
DEROCQ, D
ROCHEFORT, H
[J]. BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (01) : 37 - 45
[7] HENDERSON D, 1987, PHARM CLIN USES INHI, P184
[8] HERRMANN W, 1982, CR ACAD SCI III-VIE, V294, P933
[9] HUBER JD, 1968, STAIN TECHNOL, V43, P85
[10] LECLERCQ G, 1982, IRCS MED SCI-BIOCHEM, V10, P71